By Hafsat Ngulde
Ghana has rejected a $109 million U.S. health agreement, citing data protection risks tied to sharing sensitive national medical records with foreign entities.
The decision, confirmed by officials in Accra, places Ghana among African nations resisting new U.S. health funding frameworks requiring extensive data-sharing provisions.
The proposed five-year agreement would have funded programs targeting HIV, malaria, tuberculosis and polio across Ghana’s public health system. However, negotiators objected to clauses mandating access to sensitive health data, including patient-level and epidemiological information.
Arnold Kavaarpuo, executive director of Ghana’s Data Protection Commission, said the scope exceeded acceptable governance standards for national data.
He said provisions allowed multiple U.S. entities to access Ghana’s health datasets without prior domestic regulatory approval.
Officials warned such access could conflict with Ghana’s Data Protection Act, which restricts cross-border transfer of personal information.
Negotiations collapsed after the April 24 deadline passed without agreement, according to a source familiar with the talks. The U.S. State Department said it does not disclose details of bilateral negotiations but remains committed to partnerships with Ghana.
Ghana’s decision follows Zimbabwe’s withdrawal from a similar $367 million agreement over concerns about unequal terms and data access.
Zimbabwe’s government said the proposal required sharing biological resources without guarantees of access to resulting vaccines or treatments.
The disputes reflect growing scrutiny of Washington’s “America First Global Health Strategy,” which ties funding to data-sharing obligations. The policy replaced traditional aid channels after the shutdown of the U.S. Agency for International Development’s previous funding structures.
At least 32 agreements worth more than $20 billion have been signed globally under the initiative, U.S. officials said. Critics, including Africa Centres for Disease Control and Prevention Director Jean Kaseya, have raised concerns over data governance safeguards.
Kaseya warned agreements lack guarantees that countries sharing pathogen data would benefit from resulting vaccines or treatments.
Legal challenges have also emerged, including a Kenyan court suspension of a similar agreement over data protection concerns.
Zambia has yet to finalize a $1 billion health agreement, with U.S. officials citing lack of engagement from Lusaka.
Analysts say African governments are increasingly prioritizing data sovereignty as digital governance becomes central to national security strategies. The agreements often include provisions granting long-term access to health data, sometimes extending up to 25 years.
Public health advocates warn such clauses risk exposing sensitive information without clear oversight or reciprocal benefits.
For Ghana, rejecting the deal may create short-term funding gaps in critical health programs dependent on foreign assistance. Government health budgets remain under pressure following reductions in international aid flows over the past year.
Patients relying on donor-funded programs for HIV treatment and malaria prevention could face service disruptions if alternative funding is delayed. Health officials in Accra are now seeking to renegotiate terms that balance funding needs with stronger data governance protections.
The standoff highlights a broader shift in Africa’s engagement with external partners, emphasizing sovereignty and regulatory control over sensitive data.
Experts say the outcome of renegotiations could shape future global health partnerships and data-sharing norms across developing economies.
